LGM

Logos Global Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 197.64%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+197.64%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$899M
AUM Growth
+$198M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$67.6M
2
+$32.7M
3
+$22.6M
4
VTYX icon
Ventyx Biosciences
VTYX
+$16.9M
5
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$14.1M

Top Sells

1
+$23.7M
2
+$19.2M
3
+$16.9M
4
RCKT icon
Rocket Pharmaceuticals
RCKT
+$15.4M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$15.3M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
– –
-245,000
52
– –
-1,000,000
53
– –
-400,000
54
– –
-250,000
55
– –
-310,000
56
– –
-1,050,000
57
– –
-900,000
58
– –
-354,266
59
– –
-150,000
60
– –
-1,200,000
61
– –
-400,000
62
– –
-125,000
63
– –
-200,000
64
– –
-31,872
65
– –
-215,000
66
– –
-424,000
67
– –
-700,000
68
– –
-280,000
69
– –
-2,525,000
70
– –
-300,000
71
– –
0
1 2
3